Equity Overview
Price & Market Data
Price: $2.23
Daily Change: -$0.09 / 4.04%
Daily Range: $2.23 - $2.36
Market Cap: $205,809,360
Daily Volume: 539,950
Performance Metrics
1 Week: -7.82%
1 Month: 36.59%
3 Months: 107.4%
6 Months: 147.6%
1 Year: 183.5%
YTD: 52.38%
Company Details
Employees: 12
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.